Long-term Efficacy of Intravenous Immunoglobulin Therapy for Moderate to Severe Atopic Dermatitis in Childhood

被引:2
|
作者
Oh, J. [1 ]
Kim, J. [1 ]
Baik, H. [1 ]
Lee, H. [1 ]
机构
[1] Hanyang Univ, Guri Hosp, Kyonggi Do, South Korea
关键词
D O I
10.1016/j.jaci.2010.12.154
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:AB36 / AB36
页数:1
相关论文
共 50 条
  • [31] Emerging Role of Atopic Dermatitis Control Tool in Long-Term Monitoring of Patients With Moderate-to-Severe Atopic Dermatitis Treated With Dupilumab
    Cioppa, Vittoria
    Lazzeri, Laura
    Carraro, Andrea
    De Piano, Ernesto
    Falcinelli, Francesca
    Galluzzo, Marco
    Pallotta, Sabatino
    De Pita, Ornella
    Russo, Filomena
    DERMATITIS, 2024, 35
  • [32] Dupilumab provides long-term efficacy over 2-5 years in adults with moderate-to-severe atopic dermatitis
    Beck, L. A.
    Bissonnette, R.
    Wollenberg, A.
    Simpson, E. L.
    Thaci, D.
    Praestgaard, A.
    Aamodt, K.
    Rossi, A. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E139 - E140
  • [33] Long-term efficacy of abrocitinib in adolescents and adults with moderate-to-severe atopic dermatitis: a post hoc analysis of JADE EXTEND
    Paller, Amy S.
    Cork, Michael J.
    Flohr, Carsten
    Bangert, Christine
    Weidinger, Stephan
    Nesnas, John
    Farooqui, Saleem A.
    Biswas, Pinaki
    Watkins, Melissa
    Koppensteiner, Herwig
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [34] Parental education in the long-term management in childhood atopic dermatitis
    Suhr, KB
    Kim, YS
    Yoon, JS
    Kim, YK
    Jang, MS
    Lee, JH
    Park, JK
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (03) : 606 - 606
  • [35] Long-term systemic corticosteroid therapy in severe atopic dermatitis-Benefits of omalizumab
    Santa, C.
    Barreira, P.
    Lopes, I
    ALLERGY, 2018, 73 : 834 - 834
  • [36] Long-Term Efficacy of Treatment with Intravenous Immunoglobulin in Scleromyxedema
    Baglama, Spela
    Trcko, Katarina
    ACTA DERMATOVENEROLOGICA CROATICA, 2020, 28 (01) : 24 - 28
  • [37] Abrocitinib Long-Term Efficacy for up to 96 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis: Interim Analysis of JADE EXTEND, a Long-Term Extension Study
    Reich, Kristian
    Silverberg, Jonathan I.
    de Bruin-Weller, Marjolein
    Deleuran, Mette
    Beck, Lisa A.
    Papp, Kim
    Farooqui, Saleem A.
    Zhang, Fan
    Feeney, Claire
    Koppensteiner, Herwig
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB116 - AB116
  • [38] Long-term application of extracorporeal photochemotherapy in severe atopic dermatitis
    Prinz, B
    Michelsen, S
    Pfeiffer, C
    Plewig, G
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (04) : 577 - 582
  • [39] Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis
    Devjani, Shivali
    Engel, Priya, V
    Javadi, Sogol S.
    Smith, Brandon
    Wu, Jashin J.
    LANCET, 2023, 402 (10415): : 1833 - 1834
  • [40] Long-term follow-up in patients with moderate-to-severe atopic dermatitis treated with dupilumab
    Votto, M.
    Fortina, V.
    De Filippo, M.
    Naso, M.
    Villanova, M.
    Licari, A.
    Marseglia, G. L.
    Brazzelli, V.
    ALLERGY, 2023, 78